Effect Of Closed Kinetic Chain On Hip Stability In Spastic Cerebral Palsy Post Selective Dorsal Rhizotomy

October 15, 2024 updated by: Shaza Salah Eldin Ahmed Mostafa Elabd, Kafrelsheikh University

Purpose of the study:

To evaluate the effect of closed kinetic chain on hip stability after selective dorsal rhizotomy on spastic cerebral palsy.

Study Overview

Detailed Description

  • This is a prospective randomized controlled clinical trial, conducted at Kafr El sheikh Hospital.
  • Sixty-six children of both genders.
  • The study will include children (age 5-14years) post selective dorsal rhizotomy.
  • Children meeting the inclusion criteria will be randomly assigned to one of two groups:

    • Experimental Group: children in this group will receive closed kinetic chain.
    • Control Group: Patients in this group will receive Traditional physical therapy.
  • Randomization will be achieved using computer-generated random numbers to ensure an equal distribution of patients between the two groups.

Study Type

Interventional

Enrollment (Estimated)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kafr Elsheikh
      • Kafr Ash Shaykh, Kafr Elsheikh, Egypt
        • Faculty of physical therapy, Kafr elsheikh University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 1-Patients will be aged from 5 to 14 years

    2- will be included both genders post selective dorsal rhizotomy.

    3- The GMFCS level I-II spastic diplegia, able to stand up from a chair independently and maintain standing for more than 5 seconds without falling.

    4- Had not received any strength training program in the past 3 months before the study.

    5- Able to attend physical therapy (PT) treatment at least three a week before and during this study.

Exclusion Criteria:

  • 1-have perceptual, cognitive, visual and auditory disorder.

    2- botulinum toxin injection to the lower extremities within 6 Months.

    3- Medical conditions that prevented children from participating in the exercises.

    4- Previous lower extremity surgery, such as prior hamstring muscle Lengthening. 5- Existence of any orthopedic condition or any static hip, knee or ankle deformities.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ❖ Experimental Group: group A
Group A (study group): will include 33 children after selective dorsal rhizotomy surgery from both gender will be selected from the Outpatient Clinic. Able to attend physical therapy (PT) treatment at least three a week before and during this study. who will receive closed kinetic chain.
●Close kinetic chain exercise group: group A will receive forward step-ups, lateral step-ups, squats, sit-to-stand, and stoop-and-recover exercises. session will be initiated with a 10 min warm-up period, including stretching of the major muscles and muscle groups, then 40 min different exercises and terminated with a 10 min cool-down period in the form of aerobic exercises.
Other Names:
  • Experimental group intervention
Other: ❖ Control Group:Group B
●Group B (control group): will include 33 children who will receive Traditional physiotherapy. will include 33 children after selective dorsal rhizotomy surgery from both gender
●Traditional physiotherapy: group B will receive stretching for the lower extremity muscles, namely hip flexors and adductors, hamstrings, and calf muscles; and strengthening exercises for core muscles, hip extensors, flexors and abductors, internal and external rotators of the hip, flexors and extensors of the knee, ankle dorsi flexors, kneeling exercises, and standing and gait training
Other Names:
  • Control group intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Isokinetic dynamometry:
Time Frame: 12 weeks

Isokinetic dynamometry testing is a device used within sports and exercise science as well as clinical testing environments that is used to evaluate joint torque. Isokinetic dynamometers are able to test the strength (torque) and power of different muscle groups.

is a safe and reliable method accepted as the "gold standard" in the evaluation of muscle strength.

It will be used before and after intervention to measure muscle strength

12 weeks
X-ray:
Time Frame: 12 weeks

used to assess the alignment of the hip joint, detect any abnormalities, and determine the degree of bone deformities or hip dislocation.

Will be used before and after intervention to determine hip angles

12 weeks
The Pediatric Balance Scale:
Time Frame: 12 weeks
The Pediatric Balance Scale (PBS), which is a modification of Berg Balance Scale (BBS) designed for children and adolescents aged 5 to 15 years, to assess functional balance abilities. The scale is composed of 14 items that are scored on a criterion-based 0 to 4 scale. The range of scores in the PBS is 0 to 56. each activity is rated on a five-point scale (0-4) so that the maximum score is 56. Patients who score 41 or higher are considered to be a low fall risk, those who score between 21 and 40 are considered to be moderate fall risks, and those who score below 20 are considered to be high fall risks. It will be completed in 15-20 minutes
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Abdelaziz Ali Sherief, Professor, Kafr elsheikh university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 30, 2024

Primary Completion (Estimated)

October 12, 2024

Study Completion (Estimated)

October 20, 2024

Study Registration Dates

First Submitted

October 14, 2024

First Submitted That Met QC Criteria

October 15, 2024

First Posted (Actual)

October 17, 2024

Study Record Updates

Last Update Posted (Actual)

October 17, 2024

Last Update Submitted That Met QC Criteria

October 15, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • KFSIRB200-171

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on Close kinetic chain exercise group

Subscribe